Detection of crossed cerebellar diaschisis in hyperacute ischemic stroke using arterial spin-labeled MR imaging.

Kang KM, Sohn CH, Choi SH, Jung KH, Yoo RE, Yun TJ, Kim JH, Park SW.

PLoS One. 2017 Mar 21;12(3):e0173971. doi: 10.1371/journal.pone.0173971. eCollection 2017. 2017 3;

Identification of cerebral perfusion using arterial spin labeling in patients with seizures in acute settings.

Yoo RE, Yun TJ, Yoon BW, Lee SK, Lee ST, Kang KM, Choi SH, Kim JH, Sohn CH, Park SW, Han MH.

PLoS One. 2017 Mar 14;12(3):e0173538. doi: 10.1371/journal.pone.0173538. eCollection 2017. 2017 3;

A subpopulation of cancer stem cells identifies radiographic characteristics in glioblastoma.

Kim JE, Kim SK, Shin J, Se YB, Choi SH, Park SH, Choi SA, Lee JY, Phi JH, Wang KC, Park CK, Kim SK.

Oncol Lett. 2017 Mar;13(3):1175-1182. doi: 10.3892/ol.2016.5548. Epub 2016 Dec 28. 2017 3;

Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Yoo RE, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, You SH, Kang KM, Yun TJ, Kim JH, Sohn CH.

Eur Radiol. 2016 Dec 14. [Epub ahead of print] 2016 12;

Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.

Sunwoo L, Yun TJ, You SH, Yoo RE, Kang KM, Choi SH, Kim JH, Sohn CH, Park SW, Jung C, Park CK.

PLoS One. 2016 Nov 18;11(11):e0166662. doi: 10.1371/journal.pone.0166662. 2016 11;

The survival significance of a measurable enhancing lesion after completing standard treatment for newly diagnosed glioblastoma.

Kim SK, Kim TM, Lee ST, Lee SH, Heo DS, Kim IH, Kim DG, Jung HW, Choi SH, Lee SH, Park CK.

J Clin Neurosci. 2016 Dec;34:145-150. doi: 10.1016/j.jocn.2016.06.014. 2016 12;

Sclerosing Meningioma : Radiological and Clinical Characteristics of 21 Cases.

Kang H, Kim JW, Se YB, Dho YS, Choi SH, Park SH.

J Korean Neurosurg Soc. 2016 Nov;59(6):584-589 2016 11;

MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.

Kim BR, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH.

PLoS One. 2016 Nov 11;11(11):e0166096. doi: 10.1371/journal.pone.0166096. 2016 11;

Combined use of susceptibility weighted magnetic resonance imaging sequences and dynamic susceptibility contrast perfusion weighted imaging to improve the accuracy of the differential diagnosis of recurrence and radionec

Kim TH, Yun TJ, Park CK, Kim TM, Kim JH, Sohn CH, Won JK, Park SH, Kim IH, Choi SH.

Oncotarget. 2016 Nov 3. doi: 10.18632/oncotarget.13050. [Epub ahead of print] 2016 11;

Application of Cardiac Gating to Improve the Reproducibility of Intravoxel Incoherent Motion Measurements in the Head and Neck.

Kang KM, Choi SH, Kim DE, Yun TJ, Kim JH, Sohn CH, Park SW.

Magn Reson Med Sci. 2016 Nov 4. [Epub ahead of print] 2016 11;

Application of diffusion-weighted imaging and dynamic susceptibility contrast perfusion-weighted imaging for ganglioglioma in adults: Comparison study with oligodendroglioma.

Lee S, Yun TJ, Kang KM, Rhim JH, Park CK, Kim TM, Park SH, Kim IH, Choi SH.

J Neuroradiol. 2016 Oct;43(5):331-8. doi: 10.1016/j.neurad.2016.06.001. 2016 10;

Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Kim R, Choi SH, Yun TJ, Lee ST, Park CK, Kim TM, Kim JH, Park SW, Sohn CH, Park SH, Kim IH.

Eur Radiol. 2016 Jun 29. [Epub ahead of print] 2016 6;

Feasibility of Quantifying Arterial Cerebral Blood Volume Using Multiphase Alternate Ascending/Descending Directional Navigation (ALADDIN).

Kim KH, Choi SH, Park SH.

PLoS One. 2016 Jun 3;11(6):e0156687. doi: 10.1371/journal.pone.0156687. eCollection 2016. 2016 6;

Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity.

Kim BS, Lee ST, Yun TJ, Lee SK, Paeng JC, Jun J, Kang KM, Choi SH, Kim JH, Sohn CH.

Eur J Radiol. 2016 Jul;85(7):1295-303. doi: 10.1016/j.ejrad.2016.04.015. Epub 2016 Apr 29. 2016 4;

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma.

Cha Y, Kim YJ, Lee SH, Kim TM, Choi SH, Kim DW, Park CK, Kim IH, Kim JH, Kim E, Choi B, Kim CY, Kim IA, Heo DS.

Cancer Res Treat. 2016 May 18. doi: 10.4143/crt.2015.466. [Epub ahead of print] 2016 5;

Ultrasonographic Differentiation Between Nodular Hyperplasia and Neoplastic Follicular-Patterned Lesions of the Thyroid Gland.

Song YS, Kim JH, Na DG, Min HS, Won JK, Yun TJ, Choi SH, Sohn CH.

Ultrasound Med Biol. 2016 Aug;42(8):1816-24. doi: 10.1016/j.ultrasmedbio.2016.03.025. Epub 2016 May 8. 2016 5;

T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues.

Na JH, Lee S, Koo H, Han H, Lee KE, Han SJ, Choi SH, Kim H, Lee S, Kwon IC, Choi K, Kim K.

Nanoscale. 2016 May 5;8(18):9736-45. doi: 10.1039/c5nr06673e. 2016 5;

Predictors of survival for patients with cancer after cryptogenic stroke.

Shin YW, Lee ST, Jung KH, Kim DY, Park CK, Kim TM, Choi SH, Chu K, Lee SK.

J Neurooncol. 2016 Jun;128(2):277-84. doi: 10.1007/s11060-016-2106-0. Epub 2016 Mar 11. 2016 3;

Mapping blood flow directionality in the human brain.

Park SH, Do WJ, Choi SH, Zhao T, Bae KT.

Magn Reson Imaging. 2016 Jul;34(6):754-64. doi: 10.1016/j.mri.2016.03.005. Epub 2016 Mar 8. 2016 3;

Effect of tumor volume on the enhancement pattern of parathyroid adenoma on parathyroid four-dimensional CT.

Lee EK, Yun TJ, Kim JH, Lee KE, Kim SJ, Won JK, Kang KM, Choi SH, Sohn CH.

Neuroradiology. 2016 May;58(5):495-501. doi: 10.1007/s00234-016-1656-3. Epub 2016 Feb 5. 2016 2;